Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines.

Izetti P, Hautefeuille A, Abujamra AL, de Farias CB, Giacomazzi J, Alemar B, Lenz G, Roesler R, Schwartsmann G, Osvaldt AB, Hainaut P, Ashton-Prolla P.

Invest New Drugs. 2014 Oct;32(5):783-94. doi: 10.1007/s10637-014-0090-9. Epub 2014 May 20.

PMID:
24838627
2.

Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.

da Costa NM, Hautefeuille A, Cros MP, Melendez ME, Waters T, Swann P, Hainaut P, Pinto LF.

Cell Cycle. 2012 Dec 15;11(24):4570-8. doi: 10.4161/cc.22843. Epub 2012 Nov 19.

3.

Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells.

Lereau M, Gouas D, Villar S, Besaratinia A, Hautefeuille A, Berthillon P, Martel-Planche G, Nogueira da Costa A, Ortiz-Cuaran S, Hantz O, Pfeifer GP, Hainaut P, Chemin I.

J Gen Virol. 2012 Mar;93(Pt 3):640-650. doi: 10.1099/vir.0.032482-0. Epub 2011 Nov 23.

PMID:
22113009
4.

CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression.

Krais AM, Hautefeuille AH, Cros MP, Krutovskikh V, Tournier JM, Birembaut P, Thépot A, Paliwal A, Herceg Z, Boffetta P, Brennan P, Hainaut PL.

Carcinogenesis. 2011 Sep;32(9):1388-95. doi: 10.1093/carcin/bgr090. Epub 2011 May 17.

5.

Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.

Gouas DA, Shi H, Hautefeuille AH, Ortiz-Cuaran SL, Legros PC, Szymanska KJ, Galy O, Egevad LA, Abedi-Ardekani B, Wiman KG, Hantz O, Caron de Fromentel C, Chemin IA, Hainaut PL.

Carcinogenesis. 2010 Aug;31(8):1475-82. doi: 10.1093/carcin/bgq118. Epub 2010 Jun 10.

PMID:
20538734
6.

p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter.

Marcel V, Vijayakumar V, Fernández-Cuesta L, Hafsi H, Sagne C, Hautefeuille A, Olivier M, Hainaut P.

Oncogene. 2010 May 6;29(18):2691-700. doi: 10.1038/onc.2010.26. Epub 2010 Mar 1.

PMID:
20190805
7.

Intraepithelial p63-dependent expression of distinct components of cell adhesion complexes in normal esophageal mucosa and squamous cell carcinoma.

Thépot A, Hautefeuille A, Cros MP, Abedi-Ardekani B, Pétré A, Damour O, Krutovskikh V, Hainaut P.

Int J Cancer. 2010 Nov 1;127(9):2051-62. doi: 10.1002/ijc.25221.

8.

[Home blood pressure measurement: source of anxiety? Prospective observational study].

Hautefeuille A, Jeffredo P, Cadier S, Dessolle L, Le Reste JY.

Rev Prat. 2009 Dec 20;59(10 Suppl):3-6. French.

PMID:
20085214
9.

Characterisation of human fibroblasts as keratinocyte feeder layer using p63 isoforms status.

Auxenfans C, Thépot A, Justin V, Hautefeuille A, Shahabeddin L, Damour O, Hainaut P.

Biomed Mater Eng. 2009;19(4-5):365-72. doi: 10.3233/BME-2009-0601.

PMID:
20042803
10.

Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.

Petitjean A, Ruptier C, Tribollet V, Hautefeuille A, Chardon F, Cavard C, Puisieux A, Hainaut P, Caron de Fromentel C.

Carcinogenesis. 2008 Feb;29(2):273-81. Epub 2007 Nov 28.

PMID:
18048390
11.

In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249.

Shi H, Lambert JM, Hautefeuille A, Bykov VJ, Wiman KG, Hainaut P, Caron de Fromentel C.

Carcinogenesis. 2008 Jul;29(7):1428-34. Epub 2007 Nov 28.

PMID:
18048389
12.

Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture.

Roman S, Pétré A, Thépot A, Hautefeuille A, Scoazec JY, Mion F, Hainaut P.

Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G45-53.

13.

Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB.

Benoit V, de Moraes E, Dar NA, Taranchon E, Bours V, Hautefeuille A, Tanière P, Chariot A, Scoazec JY, de Moura Gallo CV, Merville MP, Hainaut P.

Oncogene. 2006 Sep 21;25(42):5708-18. Epub 2006 May 8.

14.

Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.

Accardi R, Dong W, Smet A, Cui R, Hautefeuille A, Gabet AS, Sylla BS, Gissmann L, Hainaut P, Tommasino M.

EMBO Rep. 2006 Mar;7(3):334-40. Epub 2006 Jan 6.

15.

Randomized controlled trial of dietary intervention: association between level of urinary phenolics and anti-mutagenicity.

Malaveille C, Fiorini L, Bianchini M, Davico L, Bertinetti S, Allegro G, Hautefeuille A, Sacerdote C, Vineis P.

Mutat Res. 2004 Jul 11;561(1-2):83-90.

PMID:
15238233
16.

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S.

Int J Cancer. 2004 Jul 1;110(4):598-604.

17.

Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.

Saintot M, Malaveille C, Hautefeuille A, Gerber M.

Eur J Cancer Prev. 2004 Feb;13(1):83-6.

PMID:
15075793
18.

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A, Porru S.

Carcinogenesis. 2004 Jun;25(6):973-8. Epub 2004 Jan 16.

PMID:
14729580
19.

Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.

Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1234-40.

20.
21.

Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies.

Airoldi L, Orsi F, Magagnotti C, Coda R, Randone D, Casetta G, Peluso M, Hautefeuille A, Malaveille C, Vineis P.

Carcinogenesis. 2002 May;23(5):861-6.

PMID:
12016161
22.

White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer.

Peluso M, Airoldi L, Magagnotti C, Fiorini L, Munnia A, Hautefeuille A, Malaveille C, Vineis P.

Carcinogenesis. 2000 Feb;21(2):183-7.

PMID:
10657956
24.

Antimutagenic dietary phenolics as antigenotoxic substances in urothelium of smokers.

Malaveille C, Hautefeuille A, Pignatelli B, Talaska G, Vineis P, Bartsch H.

Mutat Res. 1998 Jun 18;402(1-2):219-24.

PMID:
9675288
25.

4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer.

Martone T, Airoldi L, Magagnotti C, Coda R, Randone D, Malaveille C, Avanzi G, Merletti F, Hautefeuille A, Vineis P.

Int J Cancer. 1998 Feb 9;75(4):512-6.

26.

Identification of a second promoter in the human c-ets-2 proto-oncogene.

Bègue A, Crepieux P, Vu-Dac N, Hautefeuille A, Spruyt N, Laudet V, Stehelin D.

Gene Expr. 1997;6(6):333-47.

27.

Dietary phenolics as anti-mutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers.

Malaveille C, Hautefeuille A, Pignatelli B, Talaska G, Vineis P, Bartsch H.

Carcinogenesis. 1996 Oct;17(10):2193-200.

PMID:
8895488
28.

Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach.

Pignatelli B, Malaveille C, Rogatko A, Hautefeuille A, Thuillier P, Muñoz N, Moulinier B, Berger F, De Montclos H, Lambert R, et al.

Eur J Cancer. 1993;29A(14):2031-9.

PMID:
8280498
29.
30.

Levels of direct-acting mutagens, total N-nitroso compounds in nitrosated fermented fish products, consumed in a high-risk area for gastric cancer in southern China.

Chen CS, Pignatelli B, Malaveille C, Bouvier G, Shuker D, Hautefeuille A, Zhang RF, Bartsch H.

Mutat Res. 1992 Feb;265(2):211-21.

PMID:
1370720
31.

32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent.

Peluso M, Castegnaro M, Malaveille C, Friesen M, Garren L, Hautefeuille A, Vineis P, Kadlubar F, Bartsch H.

Carcinogenesis. 1991 Apr;12(4):713-7.

PMID:
2013135
32.

N-nitroso compounds, genotoxins and their precursors in gastric juice from humans with and without precancerous lesions of the stomach.

Pignatelli B, Malaveille C, Chen C, Hautefeuille A, Thuillier P, Muñoz N, Moulinier B, Berger F, De Montclos H, Ohshima H, et al.

IARC Sci Publ. 1991;(105):172-7.

PMID:
1855844
33.

Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer.

Malaveille C, Vineis P, Estéve J, Ohshima H, Brun G, Hautefeuille A, Gallet P, Ronco G, Terracini B, Bartsch H.

Carcinogenesis. 1989 Mar;10(3):577-86.

PMID:
2924402
34.
35.

Substituted hydroxyphenanthrenes in opium pyrolysates implicated in oesophageal cancer in Iran: structures and in vitro metabolic activation of a novel class of mutagens.

Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, Bartsch H.

Carcinogenesis. 1987 Oct;8(10):1423-32.

PMID:
3652380
36.
37.

Synthesis, analysis and mutagenic activity of N-nitroso derivatives of glycosylamines and Amadori compounds: nitrosated model substances for the early Maillard reaction products.

Pignatelli B, Malaveille C, Friesen M, Hautefeuille A, Bartsch H, Piskorska D, Descotes G.

IARC Sci Publ. 1987;(84):277-83.

PMID:
3679386
38.

Identification, occurrence and mutagenicity in Salmonella typhimurium of two synthetic nitroarenes, musk ambrette and musk xylene, in Indian chewing tobacco and betel quid.

Nair J, Ohshima H, Malaveille C, Friesen M, O'Neill IK, Hautefeuille A, Bartsch H.

Food Chem Toxicol. 1986 Jan;24(1):27-31.

PMID:
3512392
39.

Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran.

Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, Cabral JR, Galendo D, Lasne C, Sala M, Chouroulinkov I, et al.

Mutat Res. 1985 Jun-Jul;150(1-2):177-91.

PMID:
4000158
40.

Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.

Malaveille C, Hautefeuille A, Perin-Roussel O, Saguem S, Croisy-Delcey M, Zajdela F, Bartsch H.

Carcinogenesis. 1984 Oct;5(10):1263-6.

PMID:
6386214
41.

Lack of mutagenicity of synthetic pyrethroids in Salmonella typhimurium strains and in V79 Chinese hamster cells.

Pluijmen M, Drevon C, Montesano R, Malaveille C, Hautefeuille A, Bartsch H.

Mutat Res. 1984 Jul;137(1):7-15.

PMID:
6379439
43.

Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus.

Malaveille C, Friesen M, Camus AM, Garren L, Hautefeuille A, Béréziat JC, Ghadirian P, Day NE, Bartsch H.

Carcinogenesis. 1982;3(5):577-85.

PMID:
7046981
44.
45.

Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.

Bartsch H, Malaveille C, Camus AM, Martel-Planche G, Brun G, Hautefeuille A, Sabadie N, Barbin A, Kuroki T, Drevon C, Piccoli C, Montesano R.

Mutat Res. 1980 Jul;76(1):1-50. Review. No abstract available.

PMID:
6993936
46.

Liver microsome-mediated mutagenicity of dihydrodiols derived from dibenz(a,c)anthracene in S. typhimurium TA100.

Malaveille C, Hautefeuille A, Bartsch H, MacNicoll AD, Grover PL, Sims P.

Carcinogenesis. 1980 Mar;1(3):287-9.

PMID:
22283011
47.

Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.

Bartsch H, Malaveille C, Camus AM, Martel-Planche G, Brun G, Hautefeuille A, Sabadie N, Barbin A, Kuroki T, Drevon C, Piccoli C, Montesano R.

IARC Sci Publ. 1980;(27):179-241. No abstract available.

PMID:
7002778
48.

Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.

Malaveille C, Brun G, Hautefeuille A, Bartsch H.

Dev Toxicol Environ Sci. 1980;8:175-80. No abstract available.

PMID:
6273102
49.

Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.

Malaveille C, Kuroki T, Brun G, Hautefeuille A, Camus AM, Bartsch H.

Mutat Res. 1979 Dec;63(2):245-58.

PMID:
392308

Supplemental Content

Loading ...
Support Center